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Unlike laboratory animals, people are rarely exposed to a single hazardous chemical. However,
most of the information documenting adverse human health effects from environmental and
occupational contaminants has come from studies focused on exposure to single chemicals, and
there is little information available on how two or more contaminants affect humans. Most
information on the effects of mixtures comes from animal systems and limited investigations of
isolated human cells in culture, even though the study of mixtures in such systems has also been
neglected. Two or more compounds may show additive, antagonistic, or synergistic interactions
or may act on totally different systems and thus not interact. Furthermore, even a single chemical
may have multiple effects and affect more than one organ system. Effects may vary with age,
and metabolites may have totally different actions from the parent compound. This paper will
review the variety of health effects in humans that may result from environmental contaminants
and discuss how such contaminants may interact with each other. We will also present examples
on how different contaminants interact from toxicologic studies of polychlorinated biphenyls
performed as part of our Albany, New York, Superfund Basic Research Program project.
- Environ Health Perspect 106(Suppl 6):1263-1270 (1998). http.//ehpnet1.niehs.nih.gov/docs/
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Human exposure to environmental
contaminants is omnipresent. It does not
occur only in individuals who live next to
hazardous waste sites or just the disadvan-
taged and poor who live in inner cities or
third-world countries. Everyone carries a
burden oflead in his or her bones, mercury
in their hair, and dioxins and polychlori-
nated biphenyls (PCBs) in their body fat.
Environmental contamination is a global
issue, and contaminants in one country
often are transported to others via air,
water, foodstuffs, manufactured products,
and travelers. Environmental contaminants
may be natural substances such as metals or
radioactive materials, or they may be
manufactured products that are useful to
humans but still have toxic effects.
Contaminants maybe manufactured or they
may be unintentional by-products of
human activity, as in the case ofcombustion
or incineration products or the generation
ofchloroform as a result ofchlorination of
drinking water. Many contaminants are
mixtures ofrelated chemicals such as poly-
cyclic aromatic hydrocarbons (PAHs), crude
and refined petroleum products, and poly-
chlorinated aromatics; in some ofthese cases
even the individual components have not
been examined for toxicity.
As documentation of the widespread
degree of contamination, especially in
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developed countries, Figure 1 shows a
chromatogram of urine extracted from
wet diapers of two infant boys 1 year of
age. The peaks in the chromatogram are
identified single PCB congeners and the
dichlorodiphenyltrichloroethane metabo-
lite dichlorodiphenyldichloroethylene.
One infant (upper trace) was breast fed,
while the other (lower trace) was not. The
analyses were conducted to determine
whether the breast-fed infant had more
PCBs and pesticides in his urine than the
non-breast-fed infant, as breast milk
reflects the composition oflipophilic sub-
stances present in a mother's body fat.
What is important is that these chro-
matograms show that both infants at 1
year of age already had significant evi-
dence of exposure to a large number of
chemicals even though their dietary intake
at this age was limited. These substances
are lipophilic and are retained in body fat.
What is excreted in urine is only a small
reflection of total exposure and body bur-
den. The question of importance for the
health of these boys is not simply what
chemical X does to their development and
health, but rather what the impact is ofall
ofthese chemicals acting together.
HealthEffects ofMixtur
Some of the major broad categories of
human diseases that are suspected to result
from exposure to environmental contami-
nants are cancer, birth defects, immune
system defects, reduced intelligence quo-
tient (IQ), behavioral abnormalities,
decreased fertility, altered sex hormone
balance, altered metabolism, and specific
organ dysfunctions (2). Almost every
organ system may be affected by one or
more substances commonly found in our
environment. The diseases listed are
abstracted from many studies of both
humans and animals, and in most cases
these investigations were focused on a sin-
gle contaminant. Some of these diseases,
when expressed in a given individual, are
difficult to ascribe with certainty to a par-
ticular exposure (3). This is true for
cancer, birth defects, and many of the
endocrine disruptor and nervous system
actions. But others, such as the specific
organ system dysfunctions seen with kid-
ney disease following lead exposure (4), or
the loss of particular neurons following
methylmercury exposure (5), are clearly
attributable to particular exposures. Many
of the effects of contaminants on humans
Environmental Health Perspectives * Vol 106, Supplement 6 * December 1998 1263CARPENTER ETAL.
Figure 1. Gas spectrometry chromatograms ofurine extracts from diapers from two infants at 1 yearof age, show-
ing presence of various single PCB congeners and pesticides. Analysis was made as described by Bush et al. (1).
The infant in the upper trace was breast fed, while that in the lower trace was not. Each peak is an identified PCB
congener or pesticide.
are subtle and difficult to quantify. This is
particularly true for alterations that occur
during development and are thus irre-
versible, as are many ofthe effects on the
nervous system and organs that are
hormonally regulated.
There are a number of factors that
complicate the toxicologic evaluation of
mixtures. Two or more compounds may
have additive effects as a result ofacting at
the same site, altering the same process by
different mechanisms, or as a result ofone
compound altering the metabolism ofthe
second in such a way as to generate a toxic
metabolite. They may also have antagonis-
tic effects or may be synergistic in that the
two together give much greater response
than the sum of either alone. However,
they also may have absolutely no interac-
tions, with each substance acting indepen-
dently. In this case the net effect ofthe lack
of interaction is that a person experiences
the sum ofthe different organ toxicities of
the different contaminants.
There are several complications that
must be recognized when generalizing about
mixtures and coming from what we know
about how single compounds act. First, a
single compound may have multiple sites of
action and these may be mediated by totally
different mechanisms. Second, many sub-
stances, including metals, are changed to
metabolites or conjugates in the body, and
these new products may also have biologic
activity that may or may not be similar to
the parent compound. Thus even a single
compound may become a functional mix-
ture, as will be demonstrated for a single
PCB congener and its hydroxylated metabo-
lites. Third, there may be different effects of
a single environmental contaminant at dif-
ferent ages. Lead is a clear example in that
levels ofblood lead that appear to have little
effect on neurobehavioral function in an
adult can cause an irreversible decrement in
IQ and trigger altered behavior when
impacting the developing nervous system in
the prenatal orearlypostnatal period.
Environmental Diseases Resulting
from GeneticDamage
As shown in Figure 2, there are extensive
interactions among many of the various
organ systems, such that alteration of one
may influence the function of others.
Central to many ofthe influences on bio-
logic systems are effects that occur at the
level ofgenes. Genes control almost every-
thing, not just the eye color ofour chil-
dren. Cancer is a disease of genetic
disruption. Cancer results from mutations
in genes, some induced by a variety of
environmental factors and some inherited
from mutations in previous generations.
Cancer genes may either be such as to
promote generation ofcancer (oncogenes)
or, perhaps more frequently, are mutations
that result in the loss of cancer suppressor
functions. Many different environmental
contaminants are carcinogenic, including
some metals and organics. Mutations can
cause birth defects, as normal develop-
ment is under the control ofgenetics. But
there can be other kinds ofeffects ofenvi-
ronmental contaminants mediated by
genetic dysfunction. During normal
development genes are activated or inacti-
vated at different stages, usually under the
control ofgrowth factors and hormones.
Environmental contaminants may inter-
fere with this developmental process. For
example, many of the effects ofdiethyl-
stilbestrol (DES), the estrogenic substance
given to many pregnant women some
years ago, were the result of altered
expression ofgenes regulating sexual func-
tions (6). Genes regulate many aspects of
hormonal production, brain development
and function, immune system balances,
and organ physiology, as well as cancer
and birth defects.
Environmental Contaminants
andtheImmuneSystem
There are also many direct effects of
environmental contaminants on various
organ systems. The immune system, for
example, is suppressed by some substances
such as dioxin, coplanar PCBs, and PAHs
(7). But the immune system is affected very
differently by some metals, which promote
hypersensitivity, rashes, and autoimmunity
(8). An exciting developing area ofinves-
tigation suggests that the dominance of
differentpopulations ofThelper (Th) lym-
phocytes is a major factor in an individual's
immune responsiveness. In individuals
with normal immunity, it appears that the
ThI lymphocytes predominate; these lym-
phocytes produce a particular profile of
cytokines. Individuals with hyperimmunity
(showing asthma, skin rashes, and auto-
immune syndromes) have predominately
Brain
Hormones - Genes - Reproductive
4 ,< system
Immune
system
Figure 2. Diagrammatic interactions between genetic
information and various organ systems intimately
involved in the effects ofenvironmental agents.
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Th2 lymphocytes, which produce different
cytokines (9). It has recently been demon-
strated that environmental contaminants
such as lead and mercury can alter the bal-
ance between the Thl and Th2 lympho-
cytes (10) and there is speculation that
contaminant exposure early in life may
cause permanent or at least prolonged
abnormalities in immune function.
The immune system is also intertwined
with the other hormonal systems and the
nervous system. Children exposed prena-
tally to DES show an altered immune
function (6). There is also extensive inter-
action between the nervous and immune
systems, even to the point of a common
use of messengers. Although neurotrans-
mitters and cytokines have traditionally
been considered specific to only one system
or the other, we now know that both are
used at both sites (11).
SexSteroids andtheNervousSystem
Estrogen has direct effects on neurons,
such that estrogen alters synthesis ofsome
transmitters (12), can alter neuronal struc-
ture (13,14), influences memory function
(15,16), can trigger taste aversions (17),
and can alter neuronal ionic currents (18).
Furthermore, estrogens protect neurons
against glutamate excitotoxicity (19).
Environmental Contaminants
andtheNenrous System
The nervous system is a frequent target of
toxic action. A number of organic and
inorganic compounds will cause abnor-
malities ofperipheral sensory or motor
nerves, resulting either in loss ofsensation,
abnormal sensation, or muscle weakness
(20). Since the studies ofNeedleman and
colleagues in 1979 (21), it has been
accepted that lead at remarkably low con-
centrations can cause a decrement in IQ
and also behavioral problems in children
exposed prenatally and in the early postna-
tal years. More recent studies have sug-
gested that these actions are irreversible
(22). The exact mechanisms for these ner-
vous system actions are not known.
Evidence from several laboratories suggests
that PCBs have similar effects; prenatal
exposure has resulted in decrements in
cognitive function and behavior (23,24)
that appear irreversible (25).
PolychioinatedBiphenyls
as Chemical Mixue
Polychlorinated biphenyls are interesting
compounds for illustration of the multiple
effects of both individual chemicals and
mixtures; throughout the rest ofthis paper,
examples of results of PCB research from
our group in Albany, New York, will be
interposed. There are 209 possible PCBs
and 75 dioxins, depending on the number
and position of the chlorines on the base
biphenyl or dioxin rings. PCBs were made
as commercial mixtures with varying
degrees of chlorination. Although their
manufacture and use in the United States
ceased in 1977 when they were recognized
to be persistent both in the environment
and in the body, they continued until
recently to be manufactured and used in
many countries of the world. Although
they are persistent, they are altered by both
physical and biologic processes because
they are vulnerable to both anaerobic and
aerobic biodegradation (26-28) and
metabolism within the body (29). In most
cases these various forms of metabolism
alter the numbers and positions of the
chlorines and do not totally degrade the
PCB. Therefore, the number ofdifferent
chemical compounds that can affect
human and animal health is not limited to
the approximately 150 congeners that were
commercially produced.
Historically, PCBs have been considered
weak dioxins. Indeed, some PCB congeners
(those that can assume a coplanar configura-
tion having chlorine atoms only in the meta
and para positions to the biphenyl bridge)
are weak activators ofthe aryl hydrocarbon
(Ah) receptor, which is known to mediate
many of the effects of 2,3,7,8 tetra-
chlorodibenzo-p-dioxin (2,3,7,8-TCDD),
the most toxic polychlorinated dioxin con-
gener (30). On the basis ofthis assumption,
some have concluded that the PCBs that
cannot assume a coplanar configuration are
nontoxic (31), but this has now been
proven incorrect. Results from our labora-
tories and those of a number of other
researchers (32-42) clearly show that
many of the 209 possible PCB congeners
have discrete profiles of toxic actions and
each congener may indeed have multiple
actions at different sites.
ortho-substituted and lower chlorinated
PCBs are neurotoxic and at least three
different forms ofdirect neurotoxic actions
have been demonstrated. Shain et al. (32)
showed that congeners with two or more
ortho chlorines inhibit the enzyme tyrosine
hydroxylase, which is the rate-limiting
enzyme for the synthesis ofthe neurotrans-
mitter dopamine. Kodavanti et al. (33) and
Carpenter et al. (34) showed that ortho-
substituted, but not coplanar, congeners kill
cerebellar granule cells by a mechanism that
probably involves disruption ofcalcium
homeostasis. Finally, Niemi et al. (35)
demonstrated that both ortho and coplanar
congeners are capable of blocking the
process oflong-term potentiation (LTP), an
electrophysiologic measure in the brain that
is thought to be correlated with cognitive
function (43).
In addition to the direct effects of
estrogens on neurons discussed above,
other endocrine systems are important to
nervous system function. One such sys-
tem is the thyroid. The thyroid controls
the rate ofmetabolism and is essential to
organ development as well as daily func-
tion. Congenital hypothyroidism, even if
treated after birth, results in a syndrome
of minimal brain dysfunction (44). One
end of the structure of the thyroid hor-
mone shows some steric features similar to
PCBs and dioxins and their hydroxylated
metabolites. These substances interfere
with normal thyroid function in a variety
ofways, as outlined in Figure 3. Several
Hypothalamus
T
TRH Effects of PCBs
Pituitary
TSH
Thyroid
gland
T4
T3
Increased
Altered structure,
increased weight
Decreased due to
increased excretion
because ofdecreased
binding and increased
glucuronidation
Binding Blocksbinding,
proteins (3-8x}thanT4
Target Weakagonists
receptors and antagonists
Physical Brain Organ
growth and development maturation
metabolism
Reduced growth Minimal brain Abnormal
and metabolism dysfunction syndrome testicular
development
Figure 3. Diagrammatic indication of sites in which
polychlorinated biphenyls alter thyroid hormone func-
tion and influence development. Abbreviations: T3,
3,3',5'-triiodothyronine; T4, thyroxine; TRH, thyrotropin-
releasing hormone; TSH, thyrotropin-stimulating hor-
mone. Data from Porterfield (44), Byrne et al. (45), and
Visser etal. (46).
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Figure 5 shows the variety ofways in
No244 which xenobiotics can alter sex steroid
244 function. Substances can mimic or antago-
nize endogenous hormones. They may alter
the rates ofsynthesis or metabolism ofthe
endogenous hormone or they may directly
or indirectly alter the expression of recep-
tors for the steroid (53). These various
interactions may be complex in chemical
| | T mixtures, with each individual compound
PTU
n=4
Figure 4. Additive effects of hypothyroidism induced
by chronic treatment of developing animals with PTU,
as described by Niemi et al. (47), and acute exposure
of isolated hippocampal brain slices to 2,4,4'-TrCB on
LTP, recorded in hippocampal area CA1, as described
by Niemi et al. 135). Each bar represents the magnitude
and SEM of the increase in the population excitatory
postsynaptic potential (EPSP) induced by a tetanic acti-
vation of the synaptic input, which reflects LTP. Acute
incubation of the brain slice with 1 pM 2,4,4'-TrCB
resulted in about 50% reduction of LTP (right). Slices
obtained from animals exposed to PTU postnatally, as
described by Niemi et al. (47), also showed about 50%
reduction in LTP as compared to control slices (no 244).
When slices prepared from animals exposed to PTU
were acutely incubated in the PCB congener, there was
no LTPwhatsoever (left, 244).
potentially having multiple actions and
different compounds in the mixture
potentially acting at different sites that
influence the same final outcome.
Figure 6 illustrates ways in which PCBs
influence estrogenic function. Those copla-
nar PCBs that, like 2,3,7,8-TCDD, acti-
vate the Ah receptor, cause the induction
ofcytochrome P450s (CYP) ofthe CYPIA
and CYPIB gene families. These P450s
appear to catalyze the metabolism ofmany
PCB congeners and other aromatic moieties
such as endogenous hormones, including
estradiol. They are all estradiol hydroxylases
but insert the hydroxyl group at different
sites: CYPJAl at the 2 position and
CYPIB1 at the 4 position (54,55). Estradiol
can be oxidized at several positions, and the
products are reactive, rapidly metabolized
further, and excreted. Measurement ofthe
2- and 4-hydroxylated metabolites indi-
cates the relative activity ofthe two forms
of P450. When metabolism ofestradiol is
increased, functional levels fall and an
altered estrogenic function ensues. A num-
ber ofthe ortho-substituted PCBs, but not
the coplanars, produce a pattern ofenzyme
induction similar to that elicited by pheno-
barbital (56). Although the precise bio-
chemical mechanisms and protein factors
involved in this induction process are not
well characterized, elevated levels of
CYP2B, CYP2C, and CYP3A enzymes
result and have the same effect in increas-
ing metabolism and excretion. These
enzymes are primarily expressed in the
liver, although there may be limited expres-
sion in other tissues. Elevated rates of
Induction of
CYP1A, -1B Ah receptor C - Cytochromes P450
Substrates,
inhibitors Increased
metabolism
Cvol"Xo;z^~~~~~~~~ndcto ofA;n
Exclusive oinding
at gene regulatory PCBs
elements
Estrogenic or
antiestrogenic
PCB metabolites
IF Altered
Estrogen receptor * estrogen
Altered estrogenic function
Figure 5. Ways in which different substances can
cause endocrine disruption.
/Induction of
CYP2B, -2C, -2
PB receptor
3A
Figure 6. Sites of action of polychlorinated biphenyls
in altering estrogenic function. PB, phenobarbital.
Estradiol
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hepatic metabolism of estradiol are
observed in animals exposed to PCBs (57).
In contrast to CYP2B, CYP2C, and
CYP3A enzymes, CYP1A1 and CYPIBI
appear to be inducible in a number of
extrahepatic tissues including breast,
uterus, and pituitary (58,59).
Some of the metabolites produced,
especially mono- and dihydroxy PCBs,
may have estrogenic or antiestrogenic
activities oftheir own (39). In addition to
inducing P450s, however, some PCBs can
directly inhibit these enzymes. Although
some lightly chlorinated PCBs bind to the
active site ofthe P450s and hydroxylation
of the compound occurs, some of the
more heavily chlorinated congeners bind
but are difficult to hydroxylate, so they are
very effective inhibitors. Finally, through
activation of the Ah receptor, 2,3,7,8-
TCDD and probably also coplanar PCBs
may have inhibitory effects on estrogen-
regulated gene transcription by exclusive
binding at gene regulatory elements found
in the 5' flanking regions of estrogen-
responsive genes. The ligand-bound Ah
receptor appears to disrupt the estrogen
receptor-Sp 1 complex that is involved in
transcriptional activation of human
cathepsin D by interaction at an overlap-
ping xenobiotic response element (60).
There may be similar negative regulation
of other estrogen-regulated genes by the
Ah receptor.
Recent work in our laboratories using
cultured human cells (61) has demonstrated
how complex these interactions can be.
Pang and co-workers measured CYPlAI
and CYPIBI mRNA in several human cell
lines including MCF-7 cells, a human breast
cancer line (40). They demonstrated that a
number ofcoplanar congeners increased
both CYPlAI and CYP1Bi mRNAs but
ortho-substituted congeners did not. They
then investigated estradiol metabolism by
measuring levels of2- and 4-methoxyestra-
diol, produced through the action of cate-
chol-0-methyl transferase after estradiol is
hydroxylated, by gas chromatography/mass
spectrometry in the media ofexposed cells.
Although for some of the congeners there
was a good correlation between the mRNA
levels and the degree ofestrogen metabo-
lism, for others (especially 3,3',4,4',5,5'-
hexachlorobiphenyl [HxCB] and 3,3',4,4',5-
pentachlorobiphenyl [PeCB]), metabolism
was much less than otherwise expected. This
difference reflected a direct inhibition ofthe
P450, which they showed by demonstrating
that both of these congeners block the
elevation of estradiol metabolism induced
by 2,3,7,8-TCDD and by direct determi-
nation of inhibition of cDNA-expressed
human CYPIBI by 3,3',4,4',5,5'-HxCB
in 3,3',4,4',5-PeCB. Thus these two
congeners have opposing actions in this
pathway-inducing mRNA for synthesis of
an enzyme that they then directly inhibit.
Several other important conclusions
come from this investigation. Previous
studies of toxic equivalent factors (TEFs)
of PCB congeners relative to 2,3,7,8-
TCDD have been conducted primarily
using rodents or rodent-derived cell lines.
The values obtained from human cells
are quite different, and the highest TEF
is about an order of magnitude less
than that derived from rodent studies.
However, the different human cell lines
also behave somewhat differently depend-
ing on which P450s they express. Thus
the problem of extrapolation from ani-
mals to humans is complex. Also, the
most potent PCB congener in stimulating
estradiol metabolism in this study is
3,4,4',5- tetrachlorobiphenyl (TeCB), an
environmentally relevant congener that
has not been previously identified as hav-
ing high Ah receptor binding affinity nor
assigned a TEF value (62).
Although most of the antiestrogenic
actions ofPCBs can be explained by effects
on estrogen metabolism, there is also the
clear possibility ofaction at estrogen recep-
tors. Furthermore, the effects of PCB
metabolites may be different from that of
the parent compound. For example, Pang
and co-workers (40) found that 3,4,5-
TrCB was a potent inducer of CYPlAl
and CYPIBI mRNA and a promoter of
estrogen metabolism by both 2- and 4-
hydroxylation. However, this compound is
metabolized to a 4-biphenylol (Figure 7).
Gierthy and colleagues (39,63) use the
MCF-7 cell focus assay to identify estro-
genic and antiestrogenic properties of
xenobiotics; results with this parent com-
pound and its metabolite are shown in
Figure 8. In this assay, 3,4',5-TrCB is
antiestrogenic, probably as a result of
induced metabolism ofestradiol. However,
the 4-hydroxy metabolite, 3,4',5-TrCB-4-
OH, has no antiestrogenic activity but
shows clear estrogenic activity. Thus a par-
ent compound and a metabolite may have
diametrically opposite actions.
Figure 9 shows evidence that these
processes occur in whole animals and again
emphasizes how the different organ systems
are interconnected. Compound 3,3',4,4'-
TeCB is a coplanar congener that is anti-
estrogenic (37,38). This congener has no
effect on tyrosine hydroxylase activity (32).
However, 3,3',4,4'-TeCB is metabolized
to a hydroxylated compound that is estro-
genic. When developing rats are exposed
to 2,2',4,4'-TeCB, an ortho-substituted
Cl
QQci
Cl
3,4',5-Trichlorobiphenyl
HI
3,4',5-Trichloro-4-biphenylol
Figure 7. Structure of 3,4',5-trichlorobiphenyl and its
metabolic product 3,4',5-trichloro-4-biphenylol.
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Figure 8. Estrogenicity and antiestrogenicity of 3,4',5-
trichlorobiphenyl and one of its metabolic products,
tested in the MCF-7 cell focus assay as described by
Gierthy et al. (39,63). (A) Dose-response relation for
foci formation induced by E2 and the biphenylol. Note
the lack of estrogenic activity of the parent compound.
3,4',5-trichloro-4-biphenylol is estrogenic at 5 pM and
is thus 50,000 times less potent than estradiol. (B)
Antiestrogenicity tested in the presence of 10-9 M E2.
The parent PCB is antiestrogenic, whereas the hydroxy-
lated metabolic product shows no activity. Compared
to the specific estrogen receptor blocker LY 156758,
the parent PCB is approximately 100 times less potent.
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Figure 9. Dopamine concentrations in rat frontal
cortex of animals exposed perinatally to various con-
centrations of3,4,3',4'- or 2,4,2',4' tetrachlorobiphenyl,
as described by Seegal et al. (41). Note that although
the ortho-substituted 2,4,2',4'-TeCB resulted in a sig-
nificant reduction in brain dopamine levels, the copla-
nar 3,4,3',4'-TeCB caused a significant increase in
dopamine levels. The former result is thought to be due
to direct inhibition of the rate-limiting enzyme for
dopamine synthesis (tyrosine hydroxylase), whereas
the latter effect is a result ofthe activity of the hydrox-
ylated degradation product, which is estrogenic.
*p< 0.05, **p< 0.01, ***p 0.01.
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Figure 10. The normal variation of serum estrogen
levels during the ovulatory cycle. The area between the
upper and lower traces represents the range of E2 pro-
files in normally ovulating women. Data derived from
Diagnostic Products Corporation (68) and Thorneycroft
et al. (69).
congener that inhibits tyrosine hydroxylase
activity, there is a reduction in the level of
brain dopamine in the adults. However,
when animals are developmentally exposed
to 3,3',4,4'-TeCB, exactly the opposite
result is found; dopamine levels are
increased in adults, which may be due to
the estrogenic activity of the hydroxylated
metabolite of3,3',4,4'-TeCB (41).
The recent report by Arnold et al.
(64) of synergistic actions of weak
environmental estrogens has focused
attention on the possibility that weakly
active and especially persistent substances
might have effects in combination that far
exceed those expected by simple addition
of effects. Although the results of this
study have been questioned by its authors
and others (42,65,66), there remains
some evidence from behavioral studies
that synergism does occur (67). Table 1
shows results from the study by Arnold et
al. (64) (columns 2 and 3) as contrasted
with those from Arcaro et al. (42)
(columns 4 and 5), using the MCF-7
focus assay and a competitive receptor
binding assay with purified recombinant
human estrogen receptor (hER). Arnold
et al. (64) used purified recombinant
receptor directly (column 3) or expressed
this receptor in yeast together with the 13-
galactosidase (>-gal) reporter gene (col-
umn 2) to test the estrogenlike activity of
hydroxylated PCBs and pesticides. Results
in column 2 and 3 show that both the
EC50 for ,B-gal activity and the IC50 for
binding the hER are significantly lower
for a combination of the two hydroxy-
lated PCBs than for either compound
alone, indicating that in combination the
hydroxylated PCBs are significantly more
potent. Similar conclusions were drawn
for the pesticides dieldrin and endosulfan.
In the study by Arcaro et al. (42), in both
the MCF-7 cell focus assay and the hER
binding assay, hydroxylated PCBs alone
showed estrogenlike activity. However,
Table 1. Estrogenic and synergistic effects of weak xenoestrogens and mixtures.
MCF-7 focus
f-gal activity, hER binding, development, hERbinding2
Chemical EC50 pMa IC50 pMa EC50 pMb IC50 pMb
17,B-estradiol 0.0001 0.001 0.0003 0.0005
2,4,6-TCB-4'-OH 0.0070 0.055 0.22 0.079
2,3,4,5'-TCB-4'-OH 0.0180 0.12 0.72 0.015
2,4,6-TCB-4-OH and 2,3,4,5-TCB-4'-OH 0.0015 0.005 0.18 0.015
Dieldrin >33 >50 ND ND
Endosulfan >33 >50 >10 ND
Dieldrin and endosulfan 0.092 0.324 >10 ND
Abbreviations; EC50, median effective concentration; IC50, concentration that inhibits 50%; ND, not detectable.
"Data from Arnold etal. (64). bData from Arcaro et al. (42).
mixtures were not more potent, indicating
that no synergy occurred. Of the pesti-
cides studied, only endosulfan was weakly
estrogenic and the combination with
dieldrin was not synergistic.
The most important question with
regard to weak environmental estrogens is
whether they interact with endogenous
estradiol. This is an important question not
only for women of reproductive age, who
have high and fluctuating estrogen levels,
but especially for children, postmenopausal
women, and men, whose estrogen levels are
low. Figure 10 illustrates the typical fluctu-
ations ofestradiol concentration during the
ovulatory cycle. Figure 11 shows results of
the estrogenic response in MCF-7 cells to
estradiol alone, tested at 10-12 to 10-8 M,
and with three different concentrations of
the estrogenic PCB metabolite 2,4,6-TrCB-
4'-OH. It is important to note that there is
no evidence of any synergistic effect of
estradiol and 2,4,6-TrCB-4'-OH on the
response ofMCF-7 cells. We conclude that
different amounts of this estrogenic PCB
metabolite together with varying physio-
logic concentrations of estradiol do not
exhibit any synergism in the in vitro situa-
tion. However, this in vitro study does not
negate the synergism study in turtles (67),
although it does pose a challenge for build-
ing a stronger case that synergism between
environmentally relevant estrogenic
substances occurs in humans.
In summary, it is difficult to study
chemical mixtures because ofthe variety of
ways in which the components may inter-
act. However, even single compounds can
have complex actions at multiple sites,
varying with stage of development, and
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Figure 11. The estrogenic effects of three concentra-
tions of 2,4,6-trichloro-4'-biphenylol alone and
togetherwith dose-response curves of E2 in the MCF-7
cell focus assay, as described by Arcaro et al. (42). The
data show no synergistic effect when the biphenylol at
various concentrations was added togetherwith E2.
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may become functional mixtures in the
body as a result of metabolism. In reality
people are exposed to mixtures and ifwe are
ever to understand the human diseases that
people develop from exposure to environ-
mental contaminants, we must study and
understand the interactions that occur in
mixtures. At the same time, it will probably
not be possible to understand the complex-
ity of mixtures without understanding the
mechanisms whereby individual contami-
nants and their metabolites act, recognizing
all ofthe problems associated with species
and organ specificities, age-dependent
actions, dose-response relationships, and
the enormous interdependence ofthe vari-
ous organ systems that can lead to indirect
as well as direct effects.
REFERENCES AND NOTES
1. Bush B, Seegal RF, Fitzgerald E. Human monitoring of PCB
urine analysis. In: Organohalogen Compounds, Vol 1: Dioxin
'90-EPRI Seminar, Toxicology, Environment, Food,
Exposure-Risk (Hutzinger 0, Fiedler H, eds).
Bayreuth:Ecoinforma Press, 1990;509-513.
2. ATSDR. Priority Health Conditions. An Integrated Strategy
to Evaluate the Relationship between Illness and Exposure to
Hazardous Substances (Lybarger JA, Spengler RF, DeRosa
CT, eds). Atlanta, GA:Agency for Toxic Substances and
Disease Registry, 1993.
3. Sharpe RM, Shakkebaek NE. Are oestrogens involved in
falling sperm counts and disorders of the male reproductive
tract? Lancet 341:1392-1395 (1993).
4. Emmerson BT. Chronic lead nephropathy. Kidney Int 4:1-5
(1973).
5. Clarkson TW. Methylmercury toxicity to the mature and
developing nervous system: possible mechanism. In: Biological
Aspects of Metals and Metal-related Diseases (Sarkar B, ed).
NewYork:Raven Press, 1983;183-197.
6. Newbold R. Cellular and molecular effects of developmental
exposure to diethylstilbestrol: implications for other environ-
mental estrogens. Environ Health Perspect 103(Suppl
7):83-87 (1996).
7. Kerkvliet NI, Steppan LB, Brauner JA, Deyo JA, Henderson
MC, Tomar RS, Buhler DR. Influence ofthe Ah locus on the
humoral immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-
dioxin: evidence for Ah-receptor-dependent and Ah-receptor-
independent mechanisms of immunosuppression. Toxicol
Appl Pharmacol 105:26-36 (1990).
8. Waterman SJ, El-Fawal HAN, Snyder CA. Lead alters the
immunogenicity of two neural proteins: a potential mecha-
nism for the progression of lead-induced neurotoxicity.
Environ Health Perspect 102:1052-1056 (1994).
9. Swain SL, Bradley LM, Croft M, Tonkonogy S, Atkins G,
Weinberg AD, Duncan DD, Hedrick SM, Dutton RW,
Huston G. Helper T-cell subsets: phenotype, function and
role oflymphokines in regulating their development. Immunol
Rev 123:115-144 (1991).
10. Heo Y, Parsons PJ, Lawrence DA. Lead differentially modifies
cytokine production in vitro and in vivo. Toxicol Appl
Pharmacol 138:149-157 (1996).
11. Dafny N, Prieto-Gomez B, Reyes-Vasquez C. Does the
immune system communicate with the central nervous system?
J Neuroimmunol 9:1-12 (1985).
12. Pasqualini C, Olivier V, Guibert B, Frain 0, Leviel V. Acute
stimulatory effect ofestradiol on striatal dopamine synthesis. J
Neurochem 65:1651-1657 (1993).
13. Kawata M. Roles ofsteroid hormones and their receptors in
structural organization in the nervous system. Neurosci Res
24:1-46 (1995).
14. Woolley CS, McEwen BS. Estradiol regulates hippocampal
dendritic spine density via an N-methyl-D-aspartate receptor-
dependent mechanism. J Neurosci 14:7680-7687 (1994).
15. Kampen DL, Sherwin BB. Estradiol is related to visual mem-
ory in healthy young men. Behav Neurosci 110:613-617
(1996).
16. Luine V, Roderiguez M. Effects of estradiol on radial arm
maze performance ofyoung and aged rats. Behav Neural Biol
62:230-236 (1994).
17. Ganesan R, Simpkins JW. Conditioned taste aversion induced
by estradiol pellets. Physiol Behav 50:849-852 (1991).
18. Mermelstein PG, Becker JB, Surmeier DJ. Estradiol reduces
calcium currents in rat neostriatal neurons via a membrane
receptor. J Neurosci 16:595-604 (1996).
19. Singer CA, Rogers KL, Strickland TM, Dorsa DM. Estrogen
protects primary cortical neurons from glutamate toxicity.
Neurosci Lett 212:13-i6 (1996).
20. Herskowitz A, Ishii N, Schaumburg H. n-Hexane neuropa-
thy. N Engl J Med 285:82-85 (1971).
21. Needleman HL, Gunnoe C, Leviton A, Reed R, Peresie H,
Maher C, Barrett P. Deficit in psychologic and classroom per-
formance ofchildren with elevated dentine lead levels. N Engl
J Med 300:689-695 (1979).
22. Needleman HL, Schell A, Bellinger D, Leviton A, Alfred EN.
The long-term effects of exposure to low doses of lead in
childhood: an 11-year follow-up report. N Engl J Med
322:83-88 (1990).
23. Rogan WJ, Gladen BC. Neurotoxicology ofPCBs and related
compounds. Neurotoxicology 13:27-36 (1992).
24. Yu M-L, Hsu C-C, Guo YL, Lai T-J, Chen S-J, Luo, J-M.
Disordered behavior in the early-born Taiwan YuCheng chil-
dren. Chemosphere 29:2413-2422 (1994).
25. Jacobson JL, Jacobson SW. Intellectual impairment in chil-
dren exposed to polychlorinated biphenyls in utero. N Engl J
Med 355:783-789 (1996).
26. Quensen JF, Tiedje JM, Boyd SA. Reductive dechlorination
of polychlorinated biphenyls by anaerobic microorganisms
from sediments. Science 242:752-754 (1988).
27. Rhee G-Y, Sokol RC. The fate ofpolychlorinated biphenyls
in aquatic sediments. Great Lakes Res Rev 1:23-28 (1994).
28. Sokol RC, Kwon 0, Bethoney CM, Rhee G-Y. Reductive
dechlorination of polychlorinated biphenyls in St. Lawrence
River sediments and variations in dechlorination characteris-
tics. Environ Sci Technol 28:2054-2064 (1994).
29. Phillips DL, Smith AB, Burse VW, Steele GK, Needham LL,
Hannon WH. Half-life ofpolychlorinated biphenyls in occu-
pationally exposed workers. Arch Environ Health
44:351-354.
30. Ahlborg UG, Beching GC, Birnbaum LS, Brouwer A, Derks
HJGM, Feeley M, Golor G, Hanberg A, Larsen JC, Liem
AKD, et al. Toxic equivalency factors for dioxin-like PCBs.
Chemosphere 2:1049-1067 (1994).
31. Abramowicz DA. Aerobic and anaerobic biodegradation of
PCBs: a review. Crit Rev Biotech 10:241-251 (1990).
32. Shain W, Bush B, Seegal R. Neurotoxicity ofpolychlorinated
biphenyls: structure-activity relationship of individual con-
geners. Toxicol Appl Pharmacol 111:33-42 (1991).
33. Kodavanti PRS, Shin D-S, Tilson HA, Harry GJ.
Comparative effects of two polychlorinated biphenyl con-
geners on calcium homeostasis in rat cerebellar granule cells.
Toxicol Appl Pharmacol 123:97-106 (1993).
34. Carpenter DO, Stoner CRT, Lawrence DA. Flow cytometric
measurements of neuronal death triggered by PCBs.
Neurotoxicology 18:507-514 (1997).
35. Niemi WD, Audi J, Bush B, Carpenter DO. PCBs reduce
long-term potentiation in the CAl region of rat hippocam-
pus. Exp Neurol 151:26-34 (1998).
36. Ness DK, Schantz SL, Moshtaghian J, Hansen LG. Effects of
Environmental Health Perspectives * Vol 106, Supplement 6 * December 1998 1269CARPENTER ETAL.
perinatal exposure to specific PCB congeners on thyroid hor-
mone concentrations and thyroid histology in the rat. Toxicol
Lett 68:311-323 (1993).
37. Krishnan V, Safe S. Polychlorinated biphenyls (PCBs),
dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) as
antiestrogens in MCF-7 human breast cancer cells: quantitative
structure-activity relationships. Toxicol Appl Pharmacol
120:55-61 (1993).
38. Jansen HT, Cooke PS, Porcell J, Liu TC, Hansen LG.
Estrogenic and antiestrogenic cations ofPCBs in the female rat:
in vitroand in vivostudies. Reprod Toxicol 7:237-248 (1993).
39. Gierthy JF, Arcaro KF, Floyd M. Assessment of PCB estro-
genicity in a human breast cancer cell line. Chemosphere
34:1495-1505 (1997).
40. Pang S, Cao JQ, Katz BH, Hayes CL, Sutter TR, Spink DC.
Inductive and inhibitory effects ofnon-ortho-substituted poly-
chlorinated biphenyls on estrogen metabolism and human
cytochromes P450 lAI and IBI. Biochem Pharmacol (in
press).
41. Seegal RF, Brosch KO, Okoniewski RJ. Effects of in utero and
lactational exposure of the laboratory rat to 2,4,2',4'- and
3,4,3',4'-tetrachlorobiphenyl on dopamine function. Toxicol
Appl Pharmacol 146:95-103 (1997).
42. Arcaro KF, Vakharia DD, Yang Y, GierthyJF. Lack ofsynergy
ofweakly estrogenic hydroxylated polychlorinated biphenyls
and pesticides. Environ Health Perspect 106(Suppl
4):1041-1046 (1998).
43. Gomez RA, Passo Miller LD, Aoki A, Ramirez OA. Long-term
potentiation-induced synaptic changes in hippocampal dentate
gyrusofrats with an inborn low or high learning capacity. Brain
Res 537:293-297 (1990).
44. Porterfield SP. Vulnerability ofthe developing brain to thyroid
abnormalities: environmental insults to the thyroid system.
Environ Health Perspect 102(Suppl 2):125-130 (1994).
45. Byrne JJ, Carbone JP, Hanson EA. Hypothyroidism and
abnormalities in the kinetics ofthyroid hormone metabolism in
rats treated chronically with polychlorinated biphenyl and
polybrominated biphenyl. Endocrinology 121:520-527
(1987).
46. Visser TJ, Kaptein E, van Toor H, van Raaij JAGM, van den
Berg KJ, Joe CTT, van Engelen JGM, Brauwer A.
Glucuronidation ofthyroid hormone in rat liver: effects of in
vivo treatment with microsomal enzyme inducers and in vitro
assay conditions. Endocrinology 133:2177-2186 (1993).
47. Niemi WD, Slivinski K, Audi J, Rej R, Carpenter DO.
Propylthiouracil treatment reduces long-term potentiation in
area CAl of neonatal rat hippocampus. Neurosci Lett
210:127-129 (1996).
48. Spink DC, Lincoln DW, Dickerman HW, GierthyJF. 2,3,7,8-
Tetrachlorodibenzo-p-dioxin causes an extensive alteration of
1713-estradiol metabolism in MCF-7 breast tumor cells. Proc
NatlAcad Sci USA 87:6917-6921 (1990).
49. Gierthy JF, Spink BC, Figge HL, Pentecost BT, Spink DC.
Effects of2,3,7,8-tetrachlorobidenzo-p-dioxin, 12-O-tetrade-
canoylphorbol-13-acetate and 17p-estradiol on estrogen recep-
tor regulation in MCF-7 human breast cancer cells. J Clin
Biochem 60:173-184 (1996).
50. Li MH, Hansen LG. Enzyme induction and acute endocrine
effects in prepubertal female rats receiving environmental
PCB/PXDF/PCDD mixtures. Environ Health Perspect
194:712-722 (1996).
51. Colborn T, vam Saal FS, Soto AM. Developmental effects of
endocrine-disrupting chemicals in wildlife and humans.
Environ Health Perspect 101:378-384 (1993).
52. Colborn T, Dumanoski K, Myers JP. Our Stolen Future: Are
We Threatening Our Fertility, Intelligence and Survival? A
Scientific Detective Story. NewYork:Dutton, 1996.
53. Flouriot C, Pakdel F, DuCouret B, Valotaire Y. Influence of
xenobiotics on rainbow trout liver estrogen receptor and vitelle-
genin gene expression. J Mol Endocrinol 15:143-151 (1995).
54. Spink DC, Hayes CL, Young NR, Christou M, Sutter TR,
Jefcoate CR, Gierthy JF. The effects of 2,3,7,8-tetrachloro-
bidenzo-p-dioxin on estrogen metabolism in MCF-7 breast
cancer cells: evidence for induction of a novel 17,3-estradiol 4-
hydroxylase. J Steroid Biochem Mol Biol 51:251-258 (1994).
55. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, Sutter
TR. 173-estradiol hydroxylation catalyzed by human
cytochrome P450 IBI. Proc Natl Acad Sci USA
93:9776-9781 (1996).
56. Parkinson A, Safe S, Robertson LW, Thomas PE, Ryan DE,
Reik LM, Levin W. Immunochemical quantitation of
cytochrome P-450 isozymes and epoxide hydrolase in liver
microsomes from polychlorinated or polybrominated biphenyl-
treated rats. A study of structure-activity relationships. J Biol
Chem 258:5967-5976 (1983).
57. Namkung MJ, Porubek DJ, Nelson SD, Juchau MR.
Regulation of aromatic oxidation ofestradiol-17P in maternal
hepatic, fetal hepatic and placental tissues: comparative effects
ofa series of inducing agents. J Steroid Biochem 22:563-567
(1995).
58. Guengerich FP. Characterization of human microsomal
cytochrome P450 enzymes. Annu Rev Pharmacol Toxicol
29:241-264 (1989).
59. Shimada T, Hayes CL, Yamazaki H, Amin S, Hect SS,
Guengerich FP. Activation ofchemically diverse procarcino-
gens by human cytochrome P450 IBI. Cancer Res
56:2979-2984 (1996).
60. Krishnan V, Porter W, Santostefano M, Wang X, Safe S.
Molecular mechanism of inhibition of estrogen-induced
cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD) in MCF-7 cells. Mol Cell Biol 15:6710-6719
(1995).
61. Pang S. Development and application of HPLC/MS and
GC/MS methodologies to determine the effect ofpolychlori-
nated aromatic compounds on estrogen metabolism in human-
derived cell lines [PhD Dissertation]. The University at Albany
School ofPublic Health, Albany, NY, 1997.
62. Safe S. Polychlorinated biphenyls (PCBs): environmental
impact, biochemical and toxic responses, and implications for
risk assessment. Crit Rev Toxicol 24:87-149 (1994).
63. Gierthy JF, Lincoln DW, Roth KE, Bowser SS, Bennett JA,
Bradley L, Dickerman HW. Estrogen-stimulation of postcon-
fluent cell accumulation and foci formation ofhuman MCF-7
breast cancer cells. J Cell Biochem 45:177-187 (1991).
64. Arnold SF, Klotz DM, Collins BM, Vonier PM, Guillette LJ
Jr, McLachlan JA. Synergistic activation of estrogen receptor
with combinations of environmental chemicals. Science
272:1489-1491 (1996).
65. McLachlan JA. Synergistic effect ofenvironmental estrogens:
reportwithdrawn. Science 277:462-463 (1997).
66. Ramamoorthy K, Wang F, Chen I-C, Norris JD, McDonnell
DP, Leonard LS, Gaido KW, Bocchinfuso WP, Korach KS,
Safe S. Estrogenic activity ofa dieldrin/toxaphene mixture in
the mouse uterus, MCF-7 human breast cancer cells, and yeast-
based estrogen receptor assays: no apparent synergism.
Endocrinology 138:1520-1527 (1997).
67. Bergeron JM, Crews D, McLachlan JA. PCBs as environmental
estrogens: turtle sex determination as a biomarker ofenviron-
mental contamination. Environ Health Perspect 102:780-781
(1994).
68. Diagnostic Products Corporation. Publ PITK E2-F. Los
Angeles, CA:Diagnostic Products Corp., 1995
69. Thorneycroft IH, Mishell DR Jr, Stone SC, Kharma KM,
Nakamura RM. The relation ofserum 17-hydroxyprogesterone
and estradiol-171B levels during the human menstrual cycle. Am
J Obstet Gynecol 111:947-951 (1971).
1270 Environmental Health Perspectives - Vol 106, Supplement 6 * December 1998